WeLeader Biomedical Co., Ltd. (7713.TWO)
7713.TWO Stock Price Chart
Explore WeLeader Biomedical Co., Ltd. interactive price chart. Choose custom timeframes to analyze 7713.TWO price movements and trends.
7713.TWO Company Profile
Discover essential business fundamentals and corporate details for WeLeader Biomedical Co., Ltd. (7713.TWO) to support your stock research and investment decisions.
Sector
Industrials
Industry
Medical - Distribution
IPO Date
2 Jan 2024
Employees
209.00
Website
http://www.weleader.com.twCEO
Hung Jen Chen
Description
WeLeader Biomedical Co. Ltd. engages in the production and sale of medical diagnostic equipment and materials. It provides serum biochemistry integration platform, clinical care and medical information integration systems. The company was founded on April 28, 2003 and is headquartered in Kaohsiung City, Taiwan.
7713.TWO Financial Timeline
Browse a chronological timeline of WeLeader Biomedical Co., Ltd. corporate events including earnings releases, dividend announcements, and stock splits.
Earnings released on 11 Aug 2025
EPS came in at $1.10 surpassing the estimated $1.05 by +4.76%, while revenue for the quarter reached $273.09M , beating expectations by +3.44%.
Dividend declared on 3 Jun 2025
A dividend of $3.37 per share was announced, adjusted to $3.37. The dividend was paid on 3 Jul 2025.
Earnings released on 8 May 2025
EPS came in at $0.94 matching the estimated $0.94, while revenue for the quarter reached $245.13M , beating expectations by +0.46%.
Earnings released on 31 Dec 2024
EPS came in at $0.97 surpassing the estimated $0.96 by +0.73%, while revenue for the quarter reached $247.91M , missing expectations by -0.04%.
Earnings released on 30 Sept 2024
EPS came in at $1.06 , while revenue for the quarter reached $255.54M .
Earnings released on 30 Jun 2024
EPS came in at $1.00 , while revenue for the quarter reached $252.62M .
Dividend declared on 13 Jun 2024
A dividend of $2.30 per share was announced, adjusted to $2.30. The dividend was paid on 10 Jul 2024.
Earnings released on 31 Mar 2024
EPS came in at $1.06 , while revenue for the quarter reached $235.05M .
Earnings released on 31 Dec 2023
EPS came in at $0.90 , while revenue for the quarter reached $230.71M .
Earnings released on 30 Sept 2023
EPS came in at $0.98 , while revenue for the quarter reached $247.84M .
7713.TWO Stock Performance
Access detailed 7713.TWO performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.
Explore Related Stocks
Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.